Helicobacter pylori, Causation, Change in Natural History, and why Helicobacter-Positive Duodenal Ulcers Should Not Be Routinely Treated

References

• Tytgat G NJ, Rauws E AJ. Campylobacter pylori and its role in peptic ulcer disease. Gastroenterol Clin North Am 1990; 19: 183–196
   PubMed Web of Science ®Google Scholar
• Tytgat G NJ, Axon A TR, Dixon M F, Graham D Y, Lee A, Marshall B J. Helicobacter pylori: causal agent in peptic ulcer disease?. 1990; 36–45, Working Party Reports
   Google Scholar
• Graham D Y. Campylobacter pylori and peptic ulcer disease. Gastroenterology 1989; 96: 615–625
   PubMed Web of Science ®Google Scholar
• Dobrilla G, Vallaperta P, Amplatz S. Influence of ulcer healing on ulcer relapse after discontinuation of acute treatment: a pooled estimate of controlled trials. Gut 1988; 29: 181–187
   PubMed Web of Science ®Google Scholar
• Miller J P, Faragher E B. The potential impact of Campylobacter pylori on the treatment of duodenal ulcer disease. Scand J Gastroenterol 1989; 24: 39–45, Suppl 160
   Web of Science ®Google Scholar
• Marshall B J. The use of bismuth in gastroenterology. Am J Gastroenterol 1991; 86: 16–25
   PubMed Web of Science ®Google Scholar
• Mainguet P, Delmee M, Debongnie J P. Omeprazole, Campylobacter pylori, and duodenal ulcer. Lancet 1989; 2: 389–390
   PubMed Web of Science ®Google Scholar
• Biasco G, Miglioli M, Barbara L, Corinaldesi R, di Febo G. Omeprazole, Helicobacter pylori, gastritis, and duodenal ulcer. Lancet 1989; 2: 1403
   PubMed Web of Science ®Google Scholar
• Elder J P. Recent experimental and clinical studies on the pharmacology of colloidal bismuth subcitrate. Scand J Gastroenterol 1986; 21: 14–16, Suppl 122
   Web of Science ®Google Scholar
• Tytgat G NJ. Colloidal bismuth subcitrate in peptic ulcer—a review. Digestion 1987; 37: 31–41
   PubMed Web of Science ®Google Scholar
• Department of Clinical Epidemiology and Biostatistics, McMaster University. How to read clinical journals. IV. To determine etiology or causation. Can Med Ass J 1981; 124: 985–990
   PubMed Web of Science ®Google Scholar
• Soll H. Pathogenesis of peptic ulcer and implications for therapy. N Engl J Med 1990; 322: 909–916
   PubMed Web of Science ®Google Scholar
• Rauws E AJ, Tytgat G NJ. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1990; 335: 11233–11235
   Web of Science ®Google Scholar
• Logan R PH, Gummett P A, Poison R J. The recurrence of Helicobacter pylori in relation to duodenal ulcer [poster 152]. Third Workshop European Helicobacter pylori Study Group, ToledoSpain, 1990, 72, Rev Esp Enf Digest 1990, 78 Suppl I
   Google Scholar
• Barthel J S, Westblom T U, Havey A D, Gonzalez F, Everett D. Gastritis and Campylobacter pylori in healthy asymptomatic volunteers. Arch Intern Med 1988; 148: 1149–1151
   PubMedGoogle Scholar
• Dooley C P, Cohen H, Fitzgibbons P L. Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med 1989; 321: 1562–1566
   PubMed Web of Science ®Google Scholar
• Greibe J, Bugge P, Glorup T. Long-term prognosis of duodenal ulcer: follow-up study and survey of doctors' estimates. Br Med J 1977; 2: 1572–1574
   PubMed Web of Science ®Google Scholar
• Sipponen P, Seppala K, Aarynen M. Chronic gastritis and gastroduodenal ulcer: a case control study on risk of coexisting duodenal or gastric ulcer in patients with gastritis. Gut 1989; 30: 922–929
   PubMed Web of Science ®Google Scholar
• Tugwell P X. How to read clinical journals. III. To learn the clinical course and prognosis of disease. Can Med Assoc J 1981; 124: 869–872
   PubMed Web of Science ®Google Scholar
• Martin D F, May S J, Tweedle D EF. Difference in relapse rates of duodenal ulcer after healing with cimetidine or tripotassium dicitrato bismuthate. Lancet, 81(1)7–10
   Google Scholar
• Van Trappen P, Schuurmans P, Rutgeerts P. A comparative study of colloidal bismuth subcitrate and cimetidine on the healing and recurrence of duodenal ulcer. Scand J Gastroenterol 1982; 17: 23–30, Suppl 80
   Web of Science ®Google Scholar
• Shreeve D R, Klass H J, Jones P E. Comparison of cimetidine and tripotassium dicitrato bismuthate in healing and relapse of duodenal ulcers. Digestion 1983; 28: 96–101
   PubMed Web of Science ®Google Scholar
• Lee F I, Samloff I M, Hardman M. Comparison of tripotassium dicitrato bismuthate tablets with ranitidine in healing and relapse of duodenal ulcers. Lancet 1985; 1: 1299–1302
   PubMed Web of Science ®Google Scholar
• Hamilton I, O'Connor H J, Wood N C. Healing and recurrence of duodenal ulcer after treatment with tripotassium dicitrato bismuthate (TDB) tablets or cimetidine. Gut 1986; 27: 106–110
   PubMed Web of Science ®Google Scholar
• Cochlan J G, Humphries H, Dooley C. Campylobacter pylori and recurrence of duodenal ulcers—a 12-month follow-up study. Lancet 1987; 2: 1109–1111
   PubMed Web of Science ®Google Scholar
• Kang J K, Piper D W. Cimetidine and colloidal bismuth in treatment of chronic duodenal ulcer: comparison of initial healing and recurrences after healing. Digestion 1982; 23: 73–79
   PubMed Web of Science ®Google Scholar
• Bianchi Porro G, Lazzaroni M. Campylobacter pylori and ulcer recurrence. Lancet 1988; 1: 593
   PubMed Web of Science ®Google Scholar
• Marshall B J, Goodwin C S, Warren J R. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988; 2: 1437–1442
   PubMed Web of Science ®Google Scholar
• Lam S K. Duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1989; 1: 384
   PubMedGoogle Scholar
• Van Deventer G M, Elashoff J D, Reedy T J, Schneidman D, Walsh J H. A randomized study of maintenance therapy with ranitidine to prevent the recurrence of duodenal ulcer. N Engl J Med 1989; 320: 1113–1119
   PubMed Web of Science ®Google Scholar
• Chiverton S G, Hunt R H. Initial therapy and relapse of duodenal ulcer: possible acid secretory mechanisms. Gastroenterology 1989; 96: 632–639
   PubMed Web of Science ®Google Scholar
• Jones D B, Howden C W, Burget D W, Kerr G D, Hunt R H. Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs. Gut 1987; 28: 1120–1127
   PubMed Web of Science ®Google Scholar
• Burget D W, Chiverton S C, Hunt R H. Is there an optimal degree of acid suppression for healing of duodenal ulcers?. Gastroenterology 1990; 99: 345–351
   PubMed Web of Science ®Google Scholar
• Wyatt J I, Rathbone B J, Sobala G M. Gastric epithelium in the duodenum: its association with Helicobacter pylori and inflammation. J Clin Pathol 1990; 43: 981–986
   PubMed Web of Science ®Google Scholar
• Rauws E AJ, Langenberg W, Houthoff H J, Zanen C, Tytgat G NJ. Campylobacter pyloridis chronic active antral gastritis. Gastroenterology 1988; 94: 33–40
   PubMedGoogle Scholar
• Sackett D L. Rules of evidence and clinical recommendations on the use of antithrombic agents. Chest 1986; 89: 1–3, Suppl I
   Web of Science ®Google Scholar
• George L A, Borody T J, Andrews P. Cure of duodenal ulcer after eradication of Helicobacter pylori. Med J Aust 1990; 153: 145–149
   PubMed Web of Science ®Google Scholar
• Graham D Y, Lew G M, Klein P D. Factors affecting the eradication of Helicobacter pylori infection with triple therapy [poster 254]. European Helicobacter pylori Study Group, ToledoSpain, 1990, 117, Rev Esp Enf Digest 1990, 78 Suppl I, Third Workshop
   Google Scholar
• Bode G, Caletka R, Harle S, Malfertheiner P. Solubility characteristics of different bismuth salts in gastric juice [poster 220]. European Helicobacter pylori Study Group, ToledoSpain, 1990, 103, Rev Esp Enf Digest 1990, 78 Suppl I, Third Workshop
   Google Scholar
• Goodwin C S, Marshall B J, Blincow E D. Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies. J Clin Pathol 1988; 41: 207–210
   PubMed Web of Science ®Google Scholar
• Glypczynski Y, Burette A. Drug therapy for Helicobacter pylori infection: problems and pitfalls. Gastroenterology 1990; 85: 1545–1551
   Web of Science ®Google Scholar
• Becx M CMJ, Jansen A JHM, Classener H AL. Metronidazole-resistant Helicobacter pylori. Lancet 1990; 1: 539–540
   Google Scholar
• Glupczynski Y, Burette A, De Koster A. Epidemiological factors associated with metronidazole resistance in Helicobacter pylori. Lancet 1990; 1: 976–977
   Google Scholar
• Weil J, Bell G D, Powell K. Helicobacter pylori and metronidazole resistance. Lancet 1990; 2: 270
   Google Scholar
• Marshall B J, Armstrong J A, McGechie D B, Glancy R J. Attempts to fulfill Koch's postulates for pyloric campylobacter. Med J Aust 1985; 142: 436–439
   PubMed Web of Science ®Google Scholar
• Morris A, Nicholson G. Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH. Am J Gastroenterol 1987; 82: 192–199
   PubMed Web of Science ®Google Scholar
• Hunt R H. Campylobacter pylori and spontaneous hypochlorhydria. Campylobacter pylori and gastroduodenal disease, B J Rathbone, R V Heatley. Blackwell Scientific Publications, Oxford 1989, Chapter 21
   Google Scholar